Article
[Staphylokinase and its mutants: a new generation of thrombolytic agents].
Journal des maladies vasculaires - 1 Apr 1998
Lebrazi J, Elalamy I, Helft G, Samama M M
Abstract excerpt
Staphylokinase which is extracted from Staphylococci has been known for more than 40 years as a profibrinolytic compound. It has been obtained more recently by genetic engineering. Staphylokinase activates plasminogen into plasmin. It is a promising new thrombolytic agent for the treatment of acute myocardial infarction and thromboembolic disease in general. It is a fibrin specific thrombolytic agent which does...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
